Yukino Kawamura

4PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Econometric and statistical methodsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 06, 2021
Who Can Receive the Benefit of a Palbociclib Add-On in Patients With HR+HER2- Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy?

Yukino Kawamura, Akihiko Shimomura, Chikako Shimizu

|May 12, 2021
How Can We Evaluate the Electronic Patient-Reported Outcome Appropriately?

Hikaru Shojima, Akihiko Shimomura, Midori Kadowaki

|Apr 01, 2021
What Is the Optimal Model to Estimate the Benefits of Chemotherapy in Patients With Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer?

Kenju Ando, Akihiko Shimomura, Kenichi Yoshimura

|Jan 13, 2021
Suggestion for Research Design: Noninferiority Design in Elderly Patients With Soft-Tissue Sarcoma.

Masaki Uchihara, Kenichi Yoshimura, Akihiko Shimomura

Pageof 1